Hepatitis C as an epidemiological problem in the polish population
DOI:
https://doi.org/10.12775/MBS.2015.017Keywords
hepatitis C, epidemiological data, Polish population, hospital-acquired infectionAbstract
Introduction. Hepatitis C (HC) is an important medical and social problem in Poland and worldwide. The etiologic factor of the disease is the hepatitis C virus (HCV), which is transmitted by blood and blood preparation.
Objective. Epidemiological analysis of the prevalence of hepatitis C in the Polish population, based on preliminary results of scientific studies and statistical data.
Results. The estimation data show that in Poland the number of new cases increases annually by approximately 3000 patients. The HCV is characterized by a high level of genetic changeability, which contributes to the limited therapeutic possibilities and renders the development of
a vaccine impossible. Since1997 in Poland, the number of deaths due to HCV infection has been increasing, and in the nearest years it will increase several times. In Poland, hepatitis C is frequently noted among hospital-acquired infections. These infections are one of the most frequent sources of legal proceedings by patients and their families.
a vaccine. Infections with HCV are a frequent cause for bringing civil cases to court by previous patients against health care facilities for compensations for health loss related with infection acquired during diagnosing and treatment. Considering the high risk of infection with HCV virus in health facilities non-specific diagnostics should be carried out within wide range.
References
- 1. Kamińska A., Bednarska A., Radkowski M.: Extrahepatic replication of HCV virus. Przegl Epidemiol 2003; 57, 317-322.
- 2. Alter M.J.: Prevention of spread of hepatitis C. Hepatology 2002 (Suppl. 1); 36, 93-98.
- 3. Maasoumy B., Wedemeyer H.: Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenetrol 2012; 26(4), 401-412.
- 4. Choo Q.L., Kuo G., Weiner A.J., et al.: Isolation of a DNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244(4902),
-362.
- 5. Felmleem D.J., Hafirassou M.L., Lefevre M. et al.: Hepatitis C virus, cholesterol and lipoproteins-impact factor the viral life cycle and pathogenesis of liver disease. Viruses 2013; 5(5), 1292-1324.
- 6. Tyczewska A., Bąkowska-Żywicka K.: Attenuation of miR-122 – new therapy of hepatitis C? Biotechnologia 2010; 3(90), 29-35.
- 7. Halota W., Pawłowska M.: Hepatotropic virus infection. Med Sci Rev Hepatologia 2001; 1, 43-57.
- 8. Halota W., Pawłowska M., Bulik F., et al.: Serotypes of HCV in Polish population. Hepatologia Polska 1998; 5(1), 3-7.
- 9. Fabrizi F., Messa P., Martin P.: The unravelled link between chronic kidney disease and hepatitis C infection. New Journal of Science 2014; Article ID, 1-9.
- 10. World Health Report. World Health Organization. Geneva 2002.
- 11. Armstrong G.L., Wasley A., Smard E.P., et al.: The prevalence of hepatitis C virus infection in United States, 1999 through 2002. Ann Intern Med 2006; 144, 705-714.
- 12. Lavanchy D.: Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection 2011; 17(2), 107-115.
- 13. Habior A.: Liver disease a threat to Europe in the 21st century. Postępy Nauk Medycznych 2009; 2, 77-83.
- 14. Mazurek J.: Importance of definition of a case of disease in epidemiological surveillance on example of assessment of the number of hepatitis C cases. Przegl Epidemiol 2001; 55, 183-188.
- 15. Muszyńska A., Pokorna-Kałwak D., Steciwko A.: HCV infections – a growing p[ublic health problem. Terapia 2010; 5(2), 55-58.
- 16. Rosińska M., Stępień M.: Hepatitis C in Poland in 2009. Przegl Epidemiol 2011; 65, 265-269.
- 17. Rosińska M., Parda N., Stępień M.: Hepatitis C in Poland in 2011. Przegl Epidemiol 2013; 67, 353-356.
- 18. Rosińska M., Radziszewski F., Stępień M.: Hepatitis C in Poland in 2010. Przegl Epidemiol 2012; 66, 287-292.
- 19. Flisiak R., Halota W., Horban A., et al.: Prevalence and risk factors of HCV infection in Poland. Eu J Gastroenterol Hepatol 2011; 23(12), 1213-1217.
- 20. TNS OBOP. Knowledge concerning hepatitis. Report from 2011 study.
- 21. Stępień M., Rosińska M.: Studies of prevalence of HCV in Poland – where are we? Przegl Epidemiol 2011; 65, 15-20.
- 22. Magdzik W.: Hepatitis C. Most important epidemiological aspects. Przegl Epidemiol 2006; 60, 751-757.
Laskus I., Rosińska M.: Hepatitis C in Poland in 2007. Przegl Epidemiol 2009; 63, 251-254.
- 24. Main Sanitary Inspectorate. Sanitary state in Poland in 2012. Warszawa 2013.
- 25. Chowaniec Cz., Chowaniec M.: Problems with providing opinions in case of hospital-acquired infections, especially with hepatitis B and C viruses. Arch Med Sąd i Krym 2001; 51(1), 11-20.
- 26. Pałka J., Truszkiewicz W.: Hospital-acquired infections as the cause of making civil claims by patients. Arch Med Sąd Krym 2007; 57(1), 81-84.
Downloads
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 296
Number of citations: 0